Table 2 Expression and Cox regression analysis of the prognostic ubiquitination-regulation-associated lncRNAs in ccRCC patients

LINC01963

2.03 ± 0.51

0.56

0.40–0.78

< 0.001

0.61

−0.50

0.43–0.85

0.0033

AC006159.2

0.50 ± 0.50

0.56

0.3–-0.82

0.0025

0.74

−030

0.51–1.07

0.11

LY6E-DT

0.89 ± 0.65

0.66

0.51–0.85

0.0014

0.81

−0.21

0.62–1.05

0.10

AP000695.1

1.173 ± 0.69

1.50

1.20–1.86

< 0.001

1.26

0.23

0.98–1.61

0.070

AC092718.4

2.02 ± 0.66

1.71

1.40–2.09

< 0.001

1.27

0.24

1.00–1.60

0.050

AC131009.3

1.07 ± 0.50

2.05

1.58–2.65

< 0.001

1.58

0.46

1.14–2.19

0.0055

AL365203.2

1.54 ± 0.48

2.33

1.72–3.16

< 0.001

1.59

0.46

1.12–2.25

0.010

AC102953.2

0.70 ± 0.34

2.64

1.71–4.07

< 0.001

1.70

0.53

1.06–2.70

0.026

AC005083.1

2.96 ± 0.95

0.77

0.65–0.91

0.0023

AC005261.1

2.78 ± 0.55

1.83

1.38–2.42

< 0.001

AC093673.1

3.41 ± 0.63

1.80

1.41–2.29

< 0.001

AL136295.7

1.65 ± 0.52

1.63

1.21–2.19

0.0013

NORAD

6.06 ± 0.44

0.54

0.37–0.78

0.0012

RUSC1-AS1

1.17 ± 0.63

1.61

1.27–2.05

< 0.001